Functional validation experiments confirmed the mosaicism, with 70% of neutrophils and monocytes showing completely absent NADPH-oxidase activity as seen in CGD patients, and 30% of cells showing a normal profile (Fig. 1d, see Methods section). The gene discussed is FMO5; the disease is chronic granulomatous disease.